Company
Stimdia
Neuromodulation designed to help ventilated patients return to independent breathing
Also known as Stimdia Medical, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- hospitals
- Legal name
- Stimdia Medical, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Stimdia is developing innovative technology designed to help patients regain independent breathing and accelerate recovery from mechanical ventilation (MV). Unique neuromodulation technology aims to save valuable ICU time, excessive hospital costs and in many cases, patient lives.
Funding snapshot
- Total raised
- $21.1MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $16.1M2022-06-15
Funding rounds
- Round, 2022
- $16.1M2022-06-15, SEC form D sold, 14 investors
- Round, 2019
- $1.9M2019-12-14, SEC form D sold, 7 investors
- Round, 2018
- $1.1M2018-01-25, SEC form D sold, 4 investors
- Round, 2015
- $1.9M2015-12-08, SEC form D sold, 4 investors
Loading relationship preview